Patients with familial chylomicronemia syndrome have a substantially higher risk of developing acute pancreatitis. How common is this gastrointestinal disorder? Take the quiz to test your knowledge!
How well do you understand RNA-based and gene-editing treatments targeting apolipoprotein C-III and angiopoietin-like protein 3 in familial chylomicronemia syndrome? Test your knowledge of this evolving...
New FDA-approved and investigational therapies target apoC-III to reduce triglycerides in familial chylomicronemia syndrome. Can you identify how these agents work?
Patients with familial chylomicronemia syndrome have a substantially higher risk of developing acute pancreatitis. How common is this gastrointestinal disorder? Take the quiz to test your knowledge!
How well do you understand RNA-based and gene-editing treatments targeting apolipoprotein C-III and angiopoietin-like protein 3 in familial chylomicronemia syndrome? Test your knowledge of this evolving...
New FDA-approved and investigational therapies target apoC-III to reduce triglycerides in familial chylomicronemia syndrome. Can you identify how these agents work?
A 2025 review in the Journal of Clinical Lipidology proposes a North American diagnostic score to help identify familial chylomicronemia syndrome. Can you recognize its key features?
A new study sheds light on olezarsen's potential to address a critical problem in a rare genetic disorder. Can you pinpoint the mechanism it targets to reduce plasma triglyceride levels? Take our quiz to...
